A detailed history of Adell Harriman & Carpenter Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Adell Harriman & Carpenter Inc holds 63,647 shares of MRK stock, worth $6.61 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares
63,647
Previous 53,437 19.11%
Holding current value
$6.61 Million
Previous $6.62 Billion 9.25%
% of portfolio
0.53%
Previous 0.51%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$111.15 - $128.97 $1.13 Million - $1.32 Million
10,210 Added 19.11%
63,647 $7.23 Billion
Q2 2024

Aug 01, 2024

BUY
$123.8 - $132.96 $1.69 Million - $1.82 Million
13,670 Added 34.38%
53,437 $6.62 Billion
Q1 2024

Apr 25, 2024

BUY
$113.24 - $131.95 $923,585 - $1.08 Million
8,156 Added 25.8%
39,767 $5.25 Billion
Q4 2023

Feb 05, 2024

BUY
$100.18 - $109.02 $536,163 - $583,475
5,352 Added 20.38%
31,611 $3.45 Billion
Q3 2023

Nov 07, 2023

BUY
$102.95 - $114.33 $703,663 - $781,445
6,835 Added 35.19%
26,259 $2.7 Billion
Q2 2023

Aug 04, 2023

BUY
$108.61 - $118.38 $363,843 - $396,573
3,350 Added 20.84%
19,424 $2.22 Billion
Q1 2023

May 03, 2023

BUY
$102.94 - $114.86 $285,143 - $318,162
2,770 Added 20.82%
16,074 $1.71 Billion
Q4 2022

Feb 03, 2023

BUY
$87.44 - $112.11 $62,169 - $79,710
711 Added 5.65%
13,304 $1.48 Billion
Q3 2022

Nov 03, 2022

BUY
$84.53 - $94.96 $435,329 - $489,043
5,150 Added 69.19%
12,593 $1.08 Billion
Q2 2022

Aug 03, 2022

BUY
$83.49 - $94.64 $316,761 - $359,064
3,794 Added 103.97%
7,443 $678,000
Q1 2022

Apr 29, 2022

BUY
$73.51 - $82.4 $56,455 - $63,283
768 Added 26.66%
3,649 $299,000
Q4 2021

Feb 16, 2022

SELL
$72.28 - $90.54 $20,816 - $26,075
-288 Reduced 9.09%
2,881 $220,000
Q3 2021

Nov 05, 2021

BUY
$71.68 - $78.83 $227,153 - $249,812
3,169 New
3,169 $238,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $263B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Adell Harriman & Carpenter Inc Portfolio

Follow Adell Harriman & Carpenter Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adell Harriman & Carpenter Inc, based on Form 13F filings with the SEC.

News

Stay updated on Adell Harriman & Carpenter Inc with notifications on news.